General Information of the Compound
Compound ID
CP0561917
Compound Name
3-naphthalen-2-yl-5-[(2S)-pyrrolidin-2-yl]-1,2,4-oxadiazole
    Show/Hide
Structure
Formula
C16H15N3O
Molecular Weight
265.316
Canonical SMILES
C1CN[C@@H](C1)c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C16H15N3O/c1-2-5-12-10-13(8-7-11(12)4-1)15-18-16(20-19-15)14-6-3-9-17-14/h1-2,4-5,7-8,10,14,17H,3,6,9H2/t14-/m0/s1
    Show/Hide
InChIKey
NGSQNCDLZORERV-AWEZNQCLSA-N
Physicochemical Property
logP
3.3143
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
50.95
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 104900527
ChEMBL ID
CHEMBL4452655
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 34500 nM
   TI
   LI
   LO
   TS